Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
175,611,455
-
Total 13F shares
-
81,502,841
-
Share change
-
+2,837,777
-
Total reported value
-
$4,039,756,305
-
Put/Call ratio
-
179%
-
Price per share
-
$49.57
-
Number of holders
-
321
-
Value change
-
+$65,534,475
-
Number of buys
-
184
-
Number of sells
-
155
Institutional Holders of Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) as of Q4 2018
As of 31 Dec 2018,
Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) was held by
321 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
81,502,841 shares.
The largest 10 holders included
BlackRock Inc., Vanguard Group Inc, JPMORGAN CHASE & CO, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, ALLIANCEBERNSTEIN L.P., BANK OF AMERICA CORP /DE/, PRICE T ROWE ASSOCIATES INC /MD/, ZEVENBERGEN CAPITAL INVESTMENTS LLC, and JANUS HENDERSON GROUP PLC.
This page lists
321
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.